Survival of patients with ovarian cancer in central and northern Denmark, 1998-2009

Clinical Epidemiology

Volumn 3, Issue SUPPL., 2011, Pages 59-64

  Grann, Anne Fia ^a   Nørgaard, Mette ^a   Blaakær, Jan ^a   Søgaard Andersen, Erik ^b   Jacobsen, Jacob Bonde ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Mortality rate ratio; MRR; Outcome research; Ovarian neoplasm

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; DENMARK; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; OVERALL SURVIVAL; POPULATION RESEARCH;

EID: 80955124058     PISSN: None     EISSN: 11791349     Source Type: Journal    
DOI: 10.2147/clep.s20621     Document Type: Article

References (26)

1. Cancer registret 2009. http://www.sst.dk/publ/Publ2010/DOKU/Registre/Cancerregisteret2009.pdf.2011. Accessed May 18, 2011.
2. Klint A, Tryggvadottir L, Bray F, et al. Trends in the survival of patients diagnosed with cancer in female genital organs in the Nordic countries 1964-2003 followed up to the end of 2006. Acta Oncol. 2010; 49:632-643.
3. Bray F, Loos AH, Tognazzo S, et al. Ovarian cancer in Europe: crosssectional trends in incidence and mortality in 28 countries, 1953-2000. Int J Cancer. 2005;113:977-990.
4. Gatta G, Lasota MB, Verdecchia A. Survival of European women with gynaecological tumours, during the period 1978-1989. Eur J Cancer. 1998;34:2218-2225.
5. La VC, Bosetti C, Lucchini F, et al. Cancer mortality in Europe, 2000-2004, and an overview of trends since 1975. Ann Oncol. 2010; 21:1323-1360.
6. Coleman MP, Forman D, Bryant H, et al. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet. 2011;377:127-138.
7. Brun JL, Feyler A, Chene G, et al. Long-term results and prognostic factors in patients with epithelial ovarian cancer. Gynecol Oncol. 2000; 78:21-27.
8. Fujiwara K, Sakuragi N, Suzuki S, et al. First-line intraperitoneal carboplatin-based chemotherapy for 165 patients with epithelial ovarian carcinoma: results of long-term follow-up. Gynecol Oncol. 2003;90: 637-643.
9. Ottesen B, Iversen MG, Kehlet H. Surgical treatment for ovarian cancer in Denmark 2004-2007. Ugeskr Laeger. 2009;171:217-220.
10. Storm HH, Gislum M, Engholm G. Cancer survival before and after initiating the Danish Cancer Control plan. Ugeskr Laeger. 2008; 170:3065-3069.
11. Tetsche MS, Norgaard M, Jacobsen J, et al. Improved survival of patients with ovarian cancer in Northern Denmark, 1985-2004. Eur J Gynaecol Oncol. 2006;27:119-122.
12. Andersen TF, Madsen M, Jorgensen J, et al. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull. 1999;46:263-268.
13. Pedersen CB, Gotzsche H, Moller JO, et al. The Danish Civil Registration System. A cohort of eight million persons. Dan Med Bull. 2006;53:441-449.
14. Brenner H, Rachet B. Hybrid analysis for up-to-date long-term survival rates in cancer registries with delayed recording of incident cases. Eur J Cancer. 2004;40:2494-2501.
15. Kjaer SK, Storm HH. Survival of Danish cancer patients 1943-1987. Female genital organs. APMIS Suppl. 1993;33:107-121.
16. Bertelsen K, Kruhoffer A. What have we achieved in ovarian cancer? A comparison of survivals and resources in two different periods. Int J Gynecol Cancer. 1995;5:148-155.
17. Hannibal CG, Cortes R, Engholm G, et al. Survival of ovarian cancer patients in Denmark: excess mortality risk analysis of five-year relative survival in the period 1978-2002. Acta Obstet Gynecol Scand. 2008; 87:1353-1360.
18. Storm HH. Completeness of cancer registration in Denmark 1943-1966 and efficacy of record linkage procedures. Int J Epidemiol. 1988; 17:44-49.
19. Storm HH, Michelsen EV, Clemmensen IH, et al. The Danish Cancer Registry - history, content, quality and use. Dan Med Bull. 1997; 44:535-539.
20. Tetsche MS, Norgaard M, Skriver MV, et al. Accuracy of ovarian cancer ICD-10 diagnosis in a Danish population-based hospital discharge registry. Eur J Gynaecol Oncol. 2005;26:266-270.
21. Menzin AW, Gal D, Lovecchio JL. Contemporary surgical management of borderline ovarian tumors: a survey of the Society of Gynecologic Oncologists. Gynecol Oncol. 2000;78:7-9.
22. Autier P, Boniol M. Caution needed for country-specific cancer survival. Lancet. 2011;377:99-101.
23. Sackett DL, Haynes RB, Guyatt GH, et al. Clinical Epidemiology, a Basic Science for Clinical Medicine. 2nd ed. Boston: Lippincott Williams & Wilkins; 1991:305-334.
24. Du BA, Rochon J, Lamparter C, et al. Pattern of care and impact of participation in clinical studies on the outcome in ovarian cancer. Int J Gynecol Cancer. 2005;15:183-191.
25. O'Malley CD, Cress RD, Campleman SL, et al. Survival of Californian women with epithelial ovarian cancer, 1994-1996: a population-based study. Gynecol Oncol. 2003;91:608-615.
26. Tetsche MS, Norgaard M, Jacobsen J, et al. Comorbidity and ovarian cancer survival in Denmark, 1995-2005: a population-based cohort study. Int J Gynecol Cancer. 2008;18:421-427.